FDA allows testing of Aethlon’s device in Ebola patients

(Reuters) – Aethlon Medical Inc said the U.S. Food and Drug Administration approved testing of the company’s experimental device in Ebola patients. Patients will be administered for six to eight hours daily with the company’s device, Hemopurifier, until the Ebola viral load drops below 1000 copies/ml, Aethlon said on Friday. Aethlon’s Hemopurifier selectively filters viruses and toxins from blood. The approved protocol allows for a study to be conducted in up to 20 subjects in the United States, the company said. (Reporting by Natalie Grover in Bengaluru; Editing by Sriraj Kalluvila)
Go to Source

Innovative Home Exercise Program Removes Guesswork From Fitness-Based New Years Resolutions

Transform by Moveball™ is a comprehensive solution perfectly suited for every New Years fitness resolution. It is a home exercise program kit designed to kick-start 2015 with all equipment and resources necessary to incorporate regular physical activity into even the busiest schedules. (PRWeb January 02, 2015) Read the full story at http://www.prweb.com/releases/2015/01/prweb12420617.htm
Go to Source

1 55 56 57 58 59